Tuberculosis and Respiratory Diseases

  • 제66권4호
  • /
  • Pages.324-328
  • /
  • 2009
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지
DOI QR코드

DOI QR Code

항암화학치료 후 발생한 항이뇨호르몬 부적절 분비 증후군 1예

A Case of Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Chemotherapy in a Patient with Non-Small-Cell Lung Cancer

  • 이경주 (고려대학교 의과대학 내과학교실) ;
  • 문재영 (고려대학교 의과대학 내과학교실) ;
  • 이승룡 (고려대학교 의과대학 내과학교실) ;
  • 이상엽 (고려대학교 의과대학 내과학교실) ;
  • 김제형 (고려대학교 의과대학 내과학교실) ;
  • 신철 (고려대학교 의과대학 내과학교실) ;
  • 심재정 (고려대학교 의과대학 내과학교실) ;
  • 인광호 (고려대학교 의과대학 내과학교실) ;
  • 강경호 (고려대학교 의과대학 내과학교실) ;
  • 유세화 (고려대학교 의과대학 내과학교실)
  • Lee, Kyoung Ju (Department of Internal Medicine, Korea University College of Medicine) ;
  • Moon, Jae Young (Department of Internal Medicine, Korea University College of Medicine) ;
  • Lee, Sung Yong (Department of Internal Medicine, Korea University College of Medicine) ;
  • Lee, Sang Yeub (Department of Internal Medicine, Korea University College of Medicine) ;
  • Kim, Je Hyeong (Department of Internal Medicine, Korea University College of Medicine) ;
  • Shin, Chol (Department of Internal Medicine, Korea University College of Medicine) ;
  • Shim, Jae Jeong (Department of Internal Medicine, Korea University College of Medicine) ;
  • In, Kwang Ho (Department of Internal Medicine, Korea University College of Medicine) ;
  • Kang, Kyung Ho (Department of Internal Medicine, Korea University College of Medicine) ;
  • Yoo, Se Hwa (Department of Internal Medicine, Korea University College of Medicine)
  • 투고 : 2009.02.24
  • 심사 : 2009.04.10
  • 발행 : 2009.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

상기 환자는 진행성 비소세포폐암으로 진단 받고 carboplatin과 gemcitabine의 전신적 항암치료 후에 전신 쇠약 동반한 저나트륨혈증으로 병원에 내원하여 SIADH로 진단받고 carboplatin 약제 중단 후 호전되었다. 이러한 항암제 투여 후에 유발된 SIADH는 여러 가지 원인과의 감별을 요하며, carboplatin에 의해 유발된 SIADH의 보고는 드물기에 증례로 이를 문헌 고찰과 함께 보고하는 바이다.

The syndrome of inappropriate secretion of the antidiuretic hormone (SIADH) is a well recognized paraneoplastic phenomenon related to impaired water excretion, and can result in dilutional hyponatremia as well as central nervous system symptoms. It is characterized by a decrease in plasma osmolarity with inappropriately concentrated urine. The causes of SIADH are associated with pulmonary and endocrine disorders, central nervous system diseases, and malignancies, including lung cancer. The other causes of SIADH include some drugs, particularly chemotherapy agents. Anticancer drugs, such as cisplatin, vincristine, and cyclophosphamide are well known causes of SIADH but the mechanisms are unclear. Recently, we encountered a patient with advanced non-small cell lung cancer who suffered from general weakness and altered mentality after an intravenous carboplatin and gemcitabine combination.

키워드

참고문헌

  1. List AF, Hainsworth JD, Davis BW, Hande KR, Greco FA, Johnson DH. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. J Clin Oncol 1986;4:1191-8 https://doi.org/10.1200/JCO.1986.4.8.1191
  2. Sorensen JB, Andersen MK, Hansen HH. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med 1995;238:97-110 https://doi.org/10.1111/j.1365-2796.1995.tb00907.x
  3. Fukabori T, Nakamura T, Kida T, Fujita Y, Goto T, Hiramori N, et al. Syndrome of inappropriate antidiuretic hormone secretion following cisplatinum and vindesine administration in a patient with squamous cell carcinoma of the lung. Gan To Kagaku Ryoho 1991;18:1213-6
  4. Ishii K, Aoki Y, Sasaki M, Tanaka K. Syndrome of inappropriate secretion of antidiuretic hormone induced by intraarterial cisplatin chemotherapy. Gynecol Oncol 2002;87:150-1 https://doi.org/10.1006/gyno.2002.6788
  5. Kagawa K, Fujitaka K, Isobe T, Yamasaki M, Miyazaki M, Oguri T, et al. Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion. Intern Med 2001;40:1020-3 https://doi.org/10.2169/internalmedicine.40.1020
  6. Littlewood TJ, Smith AP. Syndrome of inappropriate antidiuretic hormone secretion due to treatment of lung cancer with cisplatin. Thorax 1984;39:636-7 https://doi.org/10.1136/thx.39.8.636
  7. Fukabori T, Nakamura T, Kida T, Fujita Y, Goto T, Hiramori N, et al. Syndrome of inappropriate antidiuretic hormone secretion following cisplatinum and vindesine administration in a patient with squamous cell carcinoma of the lung. Gan To Kagaku Ryoho 1991;18:1213-6
  8. Otsuka F, Hayashi Y, Ogura T, Hayakawa N, Ikeda S, Makino H, et al. Syndrome of inappropriate secretion of antidiuretic hormone following intra-thoracic cisplatin. Intern Med 1996;35:290-4 https://doi.org/10.2169/internalmedicine.35.290
  9. Baek YS, Ryu JS, Hong SB, Yoo SS, Yu HK, Son DW, et al. Syndrome of inappropriate secretion of antidiuretic hormone following adjuvant chemotherapy with cisplatin plus paclitaxel in non-small cell lung cancer patient. Tuberc Respir Dis 2006;61:591-4 https://doi.org/10.4046/trd.2006.61.6.591
  10. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967;42:790-806 https://doi.org/10.1016/0002-9343(67)90096-4
  11. Vorherr H, Massry SG, Utiger RD, Kleeman CR. Antidiuretic principle in malignant tumor extracts from patients with inappropriate ADH syndrome. J Clin Endocrinol Metab 1968;28:162-8 https://doi.org/10.1210/jcem-28-2-162
  12. Levin L, Sealy R, Barron J. Syndrome of inappropriate antidiuretic hormone secretion following dis-dichlorodiammineplatinum II in a patient with malignant thymoma. Cancer 1982;50:2279-82 https://doi.org/10.1002/1097-0142(19821201)50:11<2279::AID-CNCR2820501109>3.0.CO;2-E
  13. Krmar RT, Ferraris JR, Ruiz SE, Dibar E, Morandi AA, Ramirez JA. Syndrome of inappropriate secretion of antidiuretic hormone in nasopharynx carcinoma. Pediatr Nephrol 1997;11:502-3 https://doi.org/10.1007/s004670050328
  14. Yokoyama Y, Shigeto T, Futagami M, Mizunuma H. Syndrome of inappropriate secretion of anti-diuretic hormone following carboplatin-paclitaxel administration in a patient with recurrent ovarian cancer. Eur J Gynaecol Oncol 2005;26:531-2
  15. Vassal G, Rubie H, Kalifa C, Hartmann O, Lemerle J. Hyponatremia and renal sodium wasting in patients receiving cisplatinum. Pediatr Hematol Oncol 1987;4:337-44 https://doi.org/10.3109/08880018709141287

피인용 문헌

  1. Case of Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Patient with Esophageal Cancer vol.88, pp.2, 2009, https://doi.org/10.3904/kjm.2015.88.2.231